Y-mAbs Therapeutics (NASDAQ: YMAB) Completes FDA Pre-BLA Meeting for Omburtamab
Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) is engaged as a commercial-stage biopharmaceutical company, which is focused on the research, development and ...
Wednesday, February 8, 2023
Tag: healthcare stocks
Galera Therapeutics, Inc. (NASDAQ: GRTX) Reports Phase 3 ROMAN Trial of Avasopasem Met Statistically Significant Primary Endpoint
Galera Therapeutics, Inc. (NASDAQ: GRTX) is engaged as a clinical-stage biopharmaceutical company, which is focused on the research, development and ...
HCW Biologics, Inc. (NASDAQ: HCWB) Shares Soar After FDA Provided Clearance for HCW9218’s Phase 1b Clinical Trial for Treatment of Pancreatic Cancer
HCW Biologics, Inc. (NASDAQ: HCWB) is engaged as a biotechnology company, which is primarily focused on the research, discovery and ...
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) Rallies 60% After Releasing Positive Phase 2 Clinical Trials Data on Treatment of Acute Schizophrenia
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) is engaged as a clinical-stage biopharmaceutical company that primarily focuses on the research, development, ...
Capricor Therapeutics, Inc. (NASDAQ: CAPR) Skyrockets 93% After Releasing Positive Results from Interim Analysis in the HOPE-2 Clinical Trial
Capricor Therapeutics, Inc. (NASDAQ: CAPR) is engaged as a biotechnology company, which is focused on the research, development, and commercialization ...
How To Play The Resurgence In Biotechnology
Good health is a key human need that will continue to see demand regardless of overall economic conditions. While treatments ...
